Latest Education News

KNeoMedia advances toward ASX reinstatement after raising nearly $2.9 million and expanding its KneoScience platform across New York City schools, including a significant new high school content rollout.

TrivarX has launched a pivotal mental health clinical trial in partnership with the US Department of Veterans Affairs, leveraging its innovative ECG-based technology to screen for major depressive episodes. The company also secured $2.25 million in funding, positioning it for regulatory milestones ahead.

Geopacific Resources has completed a $40 million entitlement offer to fund a major drilling campaign and an updated Definitive Feasibility Study for its 1.67 million ounce Woodlark Gold Project, positioning the company for significant resource growth and project advancement.

IODM Limited reported a solid Q3 FY25 with cash receipts up 18%, driven by strong UK Education segment growth and new revenue share agreements in North America.

Cluey’s Q3 FY25 results reveal a strong 24% surge in new student enrolments and a narrowing underlying EBITDA loss, signaling a pivotal step toward profitability and renewed revenue growth.

Cluey Ltd reported a 24% surge in new student enrolments in Q3 FY25 alongside a 46% reduction in cash burn, signaling improved operational efficiency and a clearer path to profitability.

Gold Hydrogen Limited is gearing up for a pivotal 2025 drilling campaign at its Ramsay Project, aiming to further appraise significant natural hydrogen and helium accumulations confirmed in prior exploration. The company also bolsters its technical team and launches a new InvestorHub to deepen stakeholder engagement.

archTIS has reported a standout March quarter with record annual recurring revenue, improved gross margins, and strategic growth through the Direktiv acquisition and new international contracts.

Biome Australia is set to expand its Activated Probiotics range with two new products targeting vaginal health and perinatal care, tapping into a booming women’s health supplements market.

BirdDog Technology reported a slight 4.1% decline in Q3 FY25 sales to A$3.6 million while progressing strongly on its next-generation product roadmap and implementing significant cost reductions.

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet the company progresses its climate ambitions with the successful Moomba CCS project and robust decarbonisation efforts.